Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Ophthalmol Retina ; 5(5): 450-457, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-32866664

RESUMEN

PURPOSE: To compare the relative number of retinal pixels and retinal area imaged using the Optos P200DTx (Optos PLC) and Zeiss Clarus 500 (Carl Zeiss Meditec AG) ultra-widefield (UWF) fundus cameras. DESIGN: Single-center retrospective cross-sectional analysis. PARTICIPANTS: Seventy-eight eyes of 46 patients. METHODS: Eyes were imaged with Optos P200DTx, single-capture, and Zeiss Clarus 500, 2 capture montages when possible, UWF fundus cameras. Relative number of pixels encompassing all foveal-centered retinal quadrants were measured. Retinal area was measured with Zeiss Clarus 500 images that were registered to the Optos P200DTx images. Patients and technicians were asked for preferences between the machines. Imaging session times were recorded. MAIN OUTCOME MEASURES: Relative number of retinal pixels and retina area captured by each fundus camera. RESULTS: Optos P200DTx consistently captured more relative pixels compared with Zeiss Clarus 500: 510.4 versus 355.6 (P < 0.001) in total with a similarly statistically significant trend in all 4 quadrants (P < 0.001 for each). For area calculation, 70 of the 78 images achieved successful registration. Optos captured a larger total retinal area: 765.6 versus 566.5 mm2 (P < 0.001) with a similarly statistically significant trend in all 4 quadrants. In the subset of 52 of 70 registered and montaged Zeiss Clarus 500 images, similar results were found. For peripheral pathologic features, Optos P200DTx captured unique findings in 28 images, and Zeiss Clarus 500 captured unique findings 1 image (P < 0.001). Among the 48 imaging sessions in which technicians preferred Optos P200DTx for 28 sessions (58%) and Zeiss Clarus 500 for 20 (42%; P = 0.15). Among patients who responded with a preference, 24 preferred Optos P200DTx and 20 preferred Zeiss Clarus 500 (P = 0.52). Average imaging session time was 4.6 minutes (standard deviation, 3.0 minutes) for Optos P200DTx and 5.2 minutes (standard deviation, 3.0 minutes) for Zeiss Clarus 500 (P = 0.17). CONCLUSIONS: In the current study, the Optos P200DTx captured statistically significantly more retinal area in all 4 quadrants compared with the Zeiss Clarus 500. No statistically significant difference was found in patient or technician preference or image acquisition time between devices.


Asunto(s)
Angiografía con Fluoresceína/instrumentación , Fóvea Central/diagnóstico por imagen , Estudios Transversales , Diseño de Equipo , Fondo de Ojo , Humanos , Reproducibilidad de los Resultados , Estudios Retrospectivos
2.
Ophthalmic Surg Lasers Imaging Retina ; 49(7): 504-509, 2018 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-30021037

RESUMEN

BACKGROUND AND OBJECTIVE: To report on the use of intravitreal steroids in the management of acute zonal occult outer retinopathy (AZOOR), a rare disorder affecting the outer retina. PATIENTS AND METHODS: Retrospective case series of nine eyes of five patients with AZOOR who received intravitreal triamcinolone acetonide (IVTA), dexamethasone intravitreal implant, and/or fluocinolone acetonide implant. Treatment response was determined by reported symptoms and multimodal imaging findings. Patients were observed for at least 1 year following intravitreal steroid treatment (range: 14 months to 63 months). RESULTS: Seven eyes received IVTA, six eyes received the dexamethasone intravitreal implant, and one eye received the fluocinolone acetonide implant. All patients experienced disease stability or improvement based on symptomatic response and multimodal imaging findings after intravitreal steroids. One eye developed central serous retinopathy, and another eye a choroidal neovascular membrane. Five of nine eyes experienced ocular hypertension. All phakic eyes developed cataracts. CONCLUSION: Intravitreal steroids effectively achieved disease stability in patients with AZOOR. [Ophthalmic Surg Lasers Imaging Retina. 2018;49:504-509.].


Asunto(s)
Glucocorticoides/administración & dosificación , Escotoma/tratamiento farmacológico , Adulto , Anciano , Catarata/inducido químicamente , Dexametasona/administración & dosificación , Dexametasona/efectos adversos , Implantes de Medicamentos , Femenino , Fluocinolona Acetonida/administración & dosificación , Fluocinolona Acetonida/efectos adversos , Glucocorticoides/efectos adversos , Humanos , Inyecciones Intravítreas , Masculino , Persona de Mediana Edad , Hipertensión Ocular/inducido químicamente , Estudios Retrospectivos , Escotoma/diagnóstico por imagen , Escotoma/fisiopatología , Tomografía de Coherencia Óptica , Agudeza Visual , Síndromes de Puntos Blancos
3.
Ophthalmol Retina ; 1(3): 179-180, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-31047418
4.
Ocul Oncol Pathol ; 2(4): 234-238, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27843902

RESUMEN

We report a case of a choroidal neovascular membrane (CNVM) associated with sclerochoroidal calcification (SCC). An asymptomatic, 72-year-old male was referred to our institution for yellow-white placoid retinal lesions of both eyes. B-scan ultrasonography confirmed the diagnosis of SCC, and indocyanine green angiography confirmed the presence of an associated CNVM. Due to enlargement of a hemorrhagic pigment epithelial detachment associated with the CNVM over the course of 7 months, the patient was treated with a series of bevacizumab injections followed by photodynamic therapy (PDT). Due to persistence of the CNVM following PDT, the lesion was finally treated with argon laser photocoagulation. We describe the clinical course of this rare complication of SCC.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...